As healthcare systems worldwide seek more resilient and efficient pathways to deliver innovative medicines, the Department of Health – Abu Dhabi (DoH) has announced a collaboration with global pharmaceutical leader MSD (Merck & Co., Inc., Rahway, New Jersey, USA) to explore the feasibility of establishing a logistics hub in Abu Dhabi's Health, Endurance, Longevity, and Medicine (HELM) Cluster.
Subject to the completion of implementation activities and applicable approvals, the MSD regional hub is expected to support the distribution of a broad portfolio of products across a number of regional markets.
Beyond strengthening regional supply chain resilience, the hub is designed to improve access to innovative therapies and create the infrastructure required to support the commercialisation and scaling of next-generation health innovations across the region.
The collaboration demonstrates the convergence between Abu Dhabi's supportive regulatory environment and the strategic requirements of global partners seeking to eliminate supply chain vulnerabilities.
Through this alliance, MSD gains direct access to a highly connected, advanced distribution ecosystem, cementing the emirate's role as a secure, regional launch market for next-generation medical solutions.
